HIV-1 Gag Protein p17 (76-84)

Product overview
Catalog Number
PPH08-0609
Sequence
H-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH
Target
HLA-A*0201-Restricted Immunodominant CD8 Epitope of the HIV Gag Protein; Immune Checkpoint Peptide
Description
The HIV-1 matrix protein p17 (p17) plays a crucial role in the virus life cycle. It is released in the extracellular space from HIV-1-infected cells and accumulates in the tissues of patients, even in those successfully treated with highly active antiretroviral therapy. Extracellular p17 deregulates the biological functions of many different cells that are directly or indirectly implicated in AIDS pathogenesis. All p17 actions depend on interaction between its functional epitope (AT20), located at the protein N-terminal region, and different receptors expressed on target cells. This finding corroborates the importance of impeding p17/p17 receptors interaction as a contribution to block AIDS. In this article we review the interaction of p17 with heparan sulfate proteoglycans (HSPGs) and with the chemokine (C-X-C motif) receptor 1 (CXCR1) and 2 (CXCR2).
Category
Catalog peptides, Biologically Active Peptides
Product Properties
Quantity

1mg, 5mg
Storage

Shipped at 4°C. Store at -20°C for one year.
Purity

> 95%
Source

Synthetic
Forma appearance

Lyophilized powder
  • For research use only
  • Not for use in diagnostic procedures

€60,00 – €300,00 Tax excluded
Contact us to request price here
Register to buy peptides
Contact us